VYGR
Voyager Therapeutics Inc
2.80$
-2.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Voyager Therapeutics Inc (VYGR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -132 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.5 | -12 | 41 | -42 | -61 | -16 | 49 | -97 | -54 | -13 | 78 | -15 | -132 | |
| – | 0.2 | 0.6 | 0.6 | 1.6 | 2.1 | 2.8 | 3.8 | 5.2 | 6.2 | 4.4 | 4.7 | 4.1 | |
| – | 0.4 | 4.0 | 6.3 | 9.2 | 16 | 16 | 15 | 11 | 9.3 | 11 | 15 | 15 | |
| – | 3.0 | 16 | 8.9 | 9.4 | 17 | 14 | 15 | 11 | 9.7 | – | – | – | |
| 0.2 | 0.5 | 56 | -13 | -2.1 | 55 | 78 | -145 | 3.3 | 20 | -67 | 35 | -29 | |
| 0.0 | 3.0 | 1.0 | 5.0 | 4.0 | 4.3 | 7.7 | 12 | 1.6 | 2.5 | 3.3 | 3.5 | 2.6 | |
| – | -3.3 | -195 | 47 | -3.7 | 26 | -90 | 113 | 66 | -7.3 | -142 | -95 | 125 | |
| – | – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | 0.1 | 105 | 0.5 | 0.6 | 0.9 | 0.7 | 0.8 | 0.6 | 0.5 | – | 19 | – | |
| 5.7 | 22 | 178 | 0.5 | 60 | 4.7 | 81 | 3.2 | 0.6 | 1.1 | 34 | 114 | 0.8 | |
| 0.3 | 6.9 | 24 | 5.3 | -5.1 | 15 | 39 | 18 | 13 | -18 | -30 | 3.8 | -6.2 | |
| -5.5 | -15 | 40 | -48 | -65 | -20 | 41 | -109 | -55 | -15 | 75 | -19 | -135 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.